Literature DB >> 7416837

Systemic-Pulmonary shunts inneonates and infants using microporous expanded polytetrafluoroethylene: immediate and late results.

J S Donahoo, T J Gardner, K Zahka, B S Kidd.   

Abstract

Thirty infants with various types of cyanotic congenitl heart disease underwent systemic-pulmonary artery shunts with a microporous polytetrafluoroethylene (PTFE) graft between May, 1976, and July, 1979. Sixteen of them were less than 1 month old, and the average age of the neonates was 5.3 days. There were no operative deaths and 5 hospital deaths, 2 related directly to the shunt. Five patients required early revision of the shunt. Relief from cyanosis was achieved in each patient. Twenty-five patients have been followed up to three and one-half years. There have been 2 late deaths and one late occlusion of the shunt. One patient outgrew the shunt and required secondary shunting procedures. Three of 30 patients have evidenced mild congestive heart failure, which has responded to digitalis. Because of the reliability and excellent late patency of the PTFE prosthesis, we consider it to be superior to a central or Potts shunt for relief from cyanosis in the neonate and infant, and as reliable as a Blalock-Taussig shunt.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416837     DOI: 10.1016/s0003-4975(10)61231-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Computational fluid dynamics characterization of blood flow in central aorta to pulmonary artery connections: importance of shunt angulation as a determinant of shear stress-induced thrombosis.

Authors:  Carey Celestin; Martin Guillot; Nancy Ross-Ascuitto; Robert Ascuitto
Journal:  Pediatr Cardiol       Date:  2014-11-18       Impact factor: 1.655

2.  Aneurysm of the right ventricular outflow tract: a complication of aorta-main pulmonary (central) shunt.

Authors:  E Welch; I Zabaleta; R Fojaco; R Perryman
Journal:  Pediatr Cardiol       Date:  1991-10       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.